文献速递前列腺癌

高危前列腺癌根治性放疗后局部失败与生存:六项随机试验个体患者数据荟萃分析

Local Failure and Survival After Definitive Radiotherapy for Aggressive Prostate Cancer: An Individual Patient-level Meta-analysis of Six Randomized Trials.
PubMed 文献 · Eur Urol · 2019-11-10

该个体患者数据荟萃分析纳入六项随机临床试验的992例高危前列腺癌患者(Gleason分级分组4级593例、5级399例),评估根治性放疗后局部失败(LF)与总生存(OS)、前列腺癌特异性生存(PCSS)及无远处转移生存(DMFS)的关系。中位随访6.4年,LF与OS(HR 1.70,95%CI 1.37-2.10)、PCSS(HR 3.10,95%CI 2.33-4.12)和DMFS(HR 1.92,95%CI 1.54-2.39)均显著相关(P<0.001)。结论认为LF是高危局限性前列腺癌的独立预后因素,值得考虑干预。

要点

  • 高危前列腺癌根治性放疗后局部失败与总生存、前列腺癌特异性生存及无远处转移生存显著相关。
  • 发生局部失败的患者后续远处转移或死亡风险更高(HR 2.46,95%CI 1.22-4.93,P=0.01)。
  • 局部失败事件值得考虑干预,可能提示 upfront 治疗强化的合理性。

核心结论

  • 局部失败是高危局限性前列腺癌根治性放疗后OS、PCSS和DMFS的独立预后因素,且部分远处转移事件发生于局部失败之后。

研究设计与样本

  • 六项随机临床试验的个体患者数据荟萃分析,共纳入992例患者(Gleason分级分组4级593例、5级399例)。
  • 采用多变量Cox比例风险模型(以局部失败为时间依赖协变量)和马尔可夫比例风险模型评估疾病状态转换的影响。

主要发现

  • 中位随访总体6.4年,存活患者7.2年。
  • 局部失败与OS显著相关(HR 1.70,95%CI 1.37-2.10,P<0.001)。
  • 局部失败与PCSS显著相关(HR 3.10,95%CI 2.33-4.12,P<0.001)。
  • 局部失败与DMFS显著相关(HR 1.92,95%CI 1.54-2.39,P<0.001)。
  • 未转换至局部失败状态的患者转换至前列腺癌特异性死亡状态的风险显著低于转换至局部失败状态者(HR 0.13,95%CI 0.04-0.41,P<0.001)。

临床怎么用

  • 局部失败事件值得考虑干预,可能为 upfront 治疗强化提供依据。
  • 上述发现是否适用于所有男性或仅适用于无显著合并症者尚待确定。

局限性

  • 上述发现是否适用于所有男性或仅适用于无显著合并症者尚待确定。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The importance of local failure (LF) after treatment of high-grade prostate cancer (PCa) with definitive radiotherapy (RT) remains unknown. OBJECTIVE: To evaluate the clinical implications of LF after definitive RT. DESIGN, SETTING, AND PARTICIPANTS: Individual patient data meta-analysis of 992 patients (593 Gleason grade group [GG] 4 and 399 GG 5) enrolled in six randomized clinical trials. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Multivariable Cox proportional hazard models were developed to evaluate the relationship between overall survival (OS), PCa-specific survival (PCSS), and distant metastasis (DM)-free survival (DMFS) and LF as a time-dependent covariate. Markov proportional hazard models were developed to evaluate the impact of specific transitions between disease states on these endpoints. RESULTS AND LIMITATIONS: Median follow-up was 6.4 yr overall and 7.2 yr for surviving patients. LF was significantly associated with OS (hazard ratio [HR] 1.70 [95% confidence interval {CI} 1.37-2.10]), PCSS (3.10 [95% CI 2.33-4.12]), and DMFS (HR 1.92 [95% CI 1.54-2.39]), p < 0.001 for all). Patients who had not transitioned to the LF state had a significantly lower hazard of transitioning to a PCa-specific death state than those who transitioned to the LF state (HR 0.13 [95% CI 0.04-0.41], p < 0.001). Additionally, patients who transitioned to the LF state had a greater hazard of DM or death (HR 2.46 [95% CI 1.22-4.93], p = 0.01) than those who did not. CONCLUSIONS: LF is an independent prognosticator of OS, PCSS, and DMFS in high-grade localized PCa and a subset of DM events that are anteceded by LF events. LF events warrant consideration for intervention, potentially suggesting a rationale for upfront treatment intensification. However, whether these findings apply to all men or just those without significant comorbidity remains to be determined. PATIENT SUMMARY: Men who experience a local recurrence of high-grade prostate cancer after receiving upfront radiation therapy are at significantly increased risks of developing metastases and dying of prostate cancer.

来源:Eur Urol,查看原文。版权归原作者所有。

引用

  1. Kishan AU, Chu FI, King CR, et al. Local Failure and Survival After Definitive Radiotherapy for Aggressive Prostate Cancer: An Individual Patient-level Meta-analysis of Six Randomized Trials. Eur Urol. 2019. PMID: 31718822. doi:10.1016/j.eururo.2019.10.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。